OR Royalties Inc. (OR)

Osisko Gold Royalties (TSE:OR) Stock Crosses Above 50 Day Moving Average – Time to Sell?

Micot Pharma Debuts MT200605 Huntington's Disease Research in a Poster Presentation at MDS 2026 and Expands Development into Neurodegenerative Diseases

Osisko Gold: I Tried To Break The Bull Case, And I'm Still Buying

Is OR Royalties (OR) a Solid Growth Stock? 3 Reasons to Think "Yes"

OR Royalties Announces Preliminary Q3 2026 GEO Deliveries

Osisko Gold Intersects 7.28 g/t Au over 16.15 m (105 m Vertical Depth), including 173.66 g/t Au over 0.60 m, and 7.13 g/t Au over 11.60 m (61 m Vertical Depth) in Lowhee Zone Underground Infill Drilling at Cariboo Gold Project

Head-To-Head Contrast: USA Rare Earth (NASDAQ:USAR) and OR Royalties (NYSE:OR)

Osisko Gold Announces Management Update

Osisko Gold Completes US$600 Million Aggregate Principal Amount of 9.250% Senior Secured Notes Offering

OR Royalties Inc (OR) Stock Down 4.2% -- Now Undervalued? GF Score: 91/100

Osisko Gold Royalties (TSE:OR) Share Price Breaks Above 50-Day Moving Average – Should You Sell?

Asset Portfolio Briefing: First Gold Production at Cuiú Cuiú, Imminent Gold Production at Amulsar, and Other Positive Updates

Osisko Gold Announces Formal Construction Decision and Development Update for the Cariboo Gold Project

Skip the Mine, Pocket the Gold: 5 Royalty Streamers Are Crushing Producers in 2026

Osisko Gold Royalties (TSE:OR) Stock Price Passes Above Fifty Day Moving Average – Here’s Why

Micot Pharma Reports Positive Operating Cash Flow and Advances Late-Stage Pipeline in 1H 2026

Osisko Gold Announces CFO Transition to Support Its Next Stage of Growth

OR Royalties Q2 Earnings Call Highlights

OR Royalties Declares Third Quarter 2026 Dividend

OR Royalties Reports 62% Year-Over-Year Increase in Revenues and Cash Flows from Operations in Q2 2026 and Continued Share Repurchases Under the Normal Course Issuer Bid